Topical Corticosteroids Market – Research Report Global Forecast till 2023

Topical Corticosteroids Market – Research Report Global Forecast till 2023

ID: MRFR/HC/2945-HCRR | September, 2018 | Region: Global | 110 pages | Half-Cooked Research Reports

Topical Corticosteroids Market Information: By Type of Formulation (Ointments, Creams, and others), By Type of Potency Class (Ultra High, High, Moderate, and Low), By Treatment (Contact Dermatitis, Insect Stings, Psoriasis, Eczema, and others), By End Users (Hospitals, Dermatology Clinics, Pharmacies, and others) - Global Forecast till 2023


Market Synopsis of the Global Topical Corticosteroids Market
Market Scenario
Corticosteroids are synthetic analogues of the natural hormones produced by the adrenal cortex. Topical corticosteroids are hydrocortisone-derivative compounds with differentiated anti-inflammatory potency.  They are used to treat many inflammatory skin diseases such as contact curative, insect stings topical corticosteroids.


Increasing prevalence of skin diseases across the globe is one of the major factors contributing to the growth of this market. Moreover, increasing geriatric population, and growing number of skin disorders cases in children boost the growth of the market.


On the other hand, the price of the topical corticosteroids and their side effects may hamper the market growth during the corresponding period.


The global topical corticosteroids market is expected to grow at a CAGR of ~5.8% during the forecast period 2017-2023.


FIGURE 1 Global Topical Corticosteroids Market, by type of potency class, 2016 (%)

Topical Corticosteroids Market


Source: World Health Organization, Centers for Disease Control and Prevention, European Society of Clinical Microbiology and Infectious Diseases, U.S. National Library of Medicine, National Organization for Rare Disorders, The American Autoimmune Related Diseases Association, The International Society for Human and Animal Mycology, Expert Interview Market Research Future Analysis, Annual report, White paper, Company Presentation


 Segments  
The global topical corticosteroids market is segmented on the basis of type of formulation, which is segmented into ointments, creams, and others.


On the basis of type of potency class, it is segmented into ultra-high, high, moderate, and low. The ultra high is further segmented into clobetasol propionate and diflorasone diacetate. The high segment is further segmented into amcinonide, betamethasone dipropionate, desoximetasone, fluocinonide, halcinonide, and others. The moderate segment is further segmented into desoximetasone, fluocinolone acetonide, fludroxycortide, hydrocortisone valerate, triamcinolone acetonide, and others. And the low segment is further segmented into betamethasone valerate, desonide, fluocinolone acetonide, and others.


On the basis of treatment, it is segmented into contact dermatitis, insect stings, psoriasis, eczema, and others.


On the basis of end user, the market is segmented into hospitals, dermatology clinics, pharmacies, and others.


Research Methodology



Topical Corticosteroids Market-


Source: World Health Organization, Centers for Disease Control and Prevention, European Society of Clinical Microbiology and Infectious Diseases, U.S. National Library of Medicine, National Organization for Rare Disorders, The American Autoimmune Related Diseases Association, The International Society for Human and Animal Mycology, Expert Interview Market Research Future Analysis, Annual report, White paper, Company Presentation

Regional Analysis of the Global Topical Corticosteroids Market                       
The American region accounted for the largest share of the global topical corticosteroids market due to increasing prevalence of skin disease and the demand for new topical products for its treatment. As per Stanford University, every year about 5.4 million new cases of skin related diseases diagnose in the US. Additionally, increasing geriatric population is another factor responsible for the market growth in the American countries.


Europe is the second largest topical corticosteroids market across the globe owing to increasing awareness regarding skin related diseases, growing market for dermatology in many European countries, and increasing investment in healthcare domain by government.


In Asia Pacific, increasing government support for research & development in healthcare domain, growing number of dermatology clinics, and increasing prevalence of skin diseases drives the growth of the market in this region.


The Middle East & Africa is expected to show a least market share due to less availability of medical facilities, and less development in healthcare domain.
 


Key Players in the Global Topical Corticosteroids Market                           


Some of the key players in this market are AstraZeneca plc, GlaxoSmithKline plc, Merck & Co., Inc., Pfizer Inc., Sandoz AG (Novartis AG), Sanofi S.A., Actimis Pharmaceuticals, Valeant Pharmaceuticals, Almirall, S.A, and Zylera Pharmaceuticals.                                                                                                 


The report on the global topical corticosteroids market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain deeper insight to the market and industry performance. The report gives a clear picture of the current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different market segments and regions

Intended Audience



  • Topical Corticosteroids Manufacturers

  • Topical Corticosteroids Suppliers

  • Research and Development (R&D) Companies

  • Market Research and Consulting Service Providers

  • Potential Investors


 

Brief TOC

1 Report Prologue

2 Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

3 Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary research

3.4 Market Size Estimation

4 Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

5. Market Factor Analysis

5.1 Porters five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain

5.3 Investment Feasibility Analysis

5.4 Price Factor Analysis

6 Global Topical Corticosteroids Market, by Type of Formulation

6.1 Introduction

6.2 Ointments

6.3 Creams

6.4 Others

7 Global Topical Corticosteroids Market, by Type of Potency Class

7.1 Introduction

7.2 Ultra High

7.2.1 Clobetasol Propionate

7.2.2 Diflorasone Diacetate

7.3 High

7.3.1 Amcinonide

7.3.2 Betamethasone Dipropionate

7.3.3 Desoximetasone

7.3.4 Fluocinonide

7.3.5 Halcinonide

7.3.6 Others

7.4 Moderate

7.4.1 Desoximetasone

7.4.2 Fluocinolone Acetonide

7.4.3 Fludroxycortide

7.4.4 Hydrocortisone Valerate

7.4.5 Triamcinolone Acetonide

7.4.6 Others

7.5 Low

7.5.1 Betamethasone Valerate

7.5.2 Desonide

7.5.3 Fluocinolone Acetonide

7.5.4 Others

8 Global Topical Corticosteroids Market, by Type of Treatment

8.1 Introduction

8.2 Contact Dermatitis

8.3 Insect Stings

8.4 Psoriasis

8.5 Eczema

8.6 Others

9 Global Topical Corticosteroids Market, by End User

9.1 Introduction

9.2 Hospitals & Clinics

9.3 Dermatology Clinics

9.4 Pharmacies

9.5 Others

10 Global Topical Corticosteroids Market by Region

10.1 Introduction

10.2 Americas

10.2.1 North America

10.2.1.1 US

10.2.1.2 Canada

10.2.2 Latin America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 UK

10.3.1.4 Italy

10.3.1.5 Spain

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Republic of Korea

10.4.5 Australia

10.4.6 Rest of Asia Pacific

10.5 Middle East & Africa

10.5.1 United Arab Emirates

10.5.2 Saudi Arabia

10.5.3 Oman

10.5.4 Kuwait

10.5.5 Qatar

10.5.6 Rest of Middle East & Africa

11 Company Landscape

11.1 Introduction

11.2 Market share Analysis

11.3 Key Development & Strategies

11.3.1 Key Developments

12 Company Profiles

12.1 Pfizer Inc.

12.1.1 Company Overview

12.1.2 Product Overview

12.1.3 Financials

12.1.4 SWOT Analysis

12.2 AstraZeneca plc

12.2.1 Company Overview

12.2.2 Product Overview

12.2.3 Financial Overview

12.2.4 Key Developments

12.2.5 SWOT Analysis

12.3 Valeant Pharmaceuticals

12.3.1 Company Overview

12.3.2 Product Overview

12.3.3 Financial Overview

12.3.4 Key Development

12.3.5 SWOT Analysis

12.4 Sanofi S.A.

12.4.1 Company Overview

12.4.2 Product/Business Segment Overview

12.4.3 Financial Overview

12.4.4 Key Development

12.4.5 SWOT Analysis

12.5 GlaxoSmithKline plc.

12.5.1 Company Overview

12.5.2 Product Overview

12.5.3 Financial overview

12.5.4 Key Developments

12.6 Actimis Pharmaceuticals

12.6.1 Company Overview

12.6.2 Product Overview

12.6.3 Financial Overview

12.6.4 Key Developments

12.7 Zylera Pharmaceuticals

12.7.1 Overview

12.7.2 Product Overview

12.7.3 Financials

12.7.4 Key Developments

12.7.5 SWOT Analysis

13 MRFR Conclusion

13.1 Key Findings

13.1.1 From CEO’s View Point

13.1.2 Unmet Needs of the Market

13.2 Key Companies to Watch

13.3 Prediction of Healthcare Industry

14 Appendix